Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Geriatrics | Gynecology | Internal Medicine | Orthopedics | Rheumatology | Institutional

Back to Journal Articles

Generic Boniva Approved for Osteoporosis

Last Updated: March 19, 2012.

 

In postmenopausal women

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 

MONDAY, March 19 (HealthDay News) -- The first generic versions of the once-monthly osteoporosis drug Boniva (ibandronate) have been approved by the U.S. Food and Drug Administration.

Osteoporosis, characterized by a thinning of the bones, is the most common type of bone disease, the agency said in a news release Monday. More common in postmenopausal women, it increases the risk of fracture, especially of the hip, spine, and wrist.

More than 40 million people in the United States have the disease or are at significant risk for it, the FDA said.

Approvals to produce generic Boniva have been granted to: Apotex Inc., Orchid Healthcare, and Mylan Pharmaceuticals. Generic drugs are medically equivalent to the brand-name versions and are subject to the same quality standards, the agency said.

Generic Boniva will be accompanied by a guide that explains potential serious reactions, including esophageal problems; pain in the muscles, bones or joints; low blood-calcium levels; and uncommon femoral fractures.

More common side effects include back pain, indigestion, extremity pain, diarrhea, headache, and muscle pain.

Brand name Boniva, produced by Genentech, was approved by the FDA in 2003.

More information

Medline Plus has more about this drug.

Copyright © 2012 HealthDay. All rights reserved.


Previous: Functional Connectivity Reduced by ECT for Severe Depression Next: Walking Speed Is a Marker for Knee Osteoarthritis

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.